Discovery Grant Program (DGP)
The Discovery Grant Program funds innovative basic research to advance understanding, detection, and treatment of blood cancers, focusing on early-stage, discovery-driven science.
Funder: Leukemia & Lymphoma Society
Due Dates: August 12, 2026 (Letter of Intent) | November 3, 2026 (Full Application)
Funding Amounts: Up to $250,000/year, max $750,000 over 3 years (includes indirect costs capped at 10%)
Summary: Supports foundational and innovative research to advance understanding, detection, and treatment of blood cancers.
Key Information: Not for clinical trials or confirmatory/drug development studies; open to established investigators worldwide.
Description
The Discovery Grant Program (DGP) is designed to promote basic research, technological innovation, and informatics pipeline development in the field of blood cancers. The program aims to support established investigators in pursuing proof-of-concept studies that can lead to significant advances in understanding blood cancer biology, disease mechanisms, detection, monitoring, and identification of novel therapeutic targets. DGP is specifically focused on early-stage, discovery-driven projects that have the potential to open new directions in blood cancer research, rather than clinical trials or confirmatory studies.
